GlassScriptPhysician profile
Vaishnavi S Bawa
NPI 1619317310
$1,704.42
in general payments reported to CMS, 2019-2025
13 companies · $73.14 in 2025
The $73.14 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,204 · 2020: $16.75 · 2021: $18.67 · 2023: $296 · 2024: $95.93 · 2025: $73.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $1,100.00 | 2019 | |
| Stryker Corporation | $194.47 | 2023-2024 | Viaflow, Allomatrix, N/A |
| Treace Medical Concepts, INC. | $117.94 | 2023 | |
| Paragon 28, INC. | $78.95 | 2019-2025 | |
| Orthofix Medical, INC. | $47.56 | 2019-2025 | Physio-Stim |
| Mimedx Group, INC. | $43.76 | 2024-2025 | |
| Horizon Therapeutics Plc | $30.33 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $20.29 | 2025 | |
| Nevro Corp. | $18.07 | 2024 | Senza |
| Smith+Nephew, INC. | $14.61 | 2019 | |
| Arthrosurface Incorporated | $13.63 | 2019 | |
| Pfizer INC. | $12.95 | 2019 | |
| Linvatec Corporation | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vaishnavi Bawa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.